StonvexLoading…
StonvexStonvexStonvexCore line items from LDOS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-02 | Annual 2025 2025-01-03 | Annual 2023 2023-12-29 | Annual 2022 2022-12-30 |
|---|---|---|---|---|
Revenue | $17.11B | $16.58B | $15.34B | $14.29B |
Operating Income | $2.11B | $1.83B | $621.00M | $1.09B |
Net Income | $1.45B | $1.25B | $199.00M | $685.00M |
EPS (Diluted) | $11.14 | $9.22 | $1.44 | $4.96 |
Total Assets | $13.49B | $13.01B | $12.70B | $13.07B |
Total Liabilities | $8.53B | $8.55B | $8.44B | $8.72B |
Cash & Equivalents | $1.11B | $849.00M | $641.00M | $516.00M |
Free Cash Flow OCF − CapEx | $1.63B | $1.29B | $980.00M | $863.00M |
Shares Outstanding | 126.38M | 131.16M | 135.77M | 136.93M |